Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Monika M Kutyna"'
Autor:
Mihir D. Wechalekar, Lin-Pierre Zhao, Monika M. Kutyna, Lih En Hong, Joule Li, Kevin Hung, Hamish S. Scott, Anna Brown, Christopher C. Hahn, Karin Kassahn, Dariusz Ladon, David T. Yeung, Daniel Thomas, Mrinal Patnaik, Susanna Proudman, Lionel Ades, Mithun V. Shah, Chung H. Kok, Devendra K. Hiwase
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-5 (2024)
Externí odkaz:
https://doaj.org/article/8a363b1a155c4c5b8cf3f98ef635b878
Autor:
Monika M. Kutyna, Chung Hoow Kok, Yoon Lim, Elizabeth Ngoc Hoa Tran, David Campbell, Sharon Paton, Chloe Thompson-Peach, Kelly Lim, Dimitrios Cakouros, Agnes Arthur, Timothy Hughes, Sharad Kumar, Daniel Thomas, Stan Gronthos, Devendra K. Hiwase
Publikováno v:
Leukemia. 36:2678-2689
Therapy-related myeloid neoplasm (tMN) is considered a direct consequence of DNA damage in hematopoietic stem cells. Despite increasing recognition that altered stroma can also drive leukemogenesis, the functional biology of the tMN microenvironment
Autor:
Rakchha Chhetri, Li Yan A. Wee, Romi Sinha, Monika M. Kutyna, Anh Pham, Helen Stathopoulos, Lakshmi Nath, Shriram V. Nath, Nicholas Wickham, Tim Hughes, Deepak Singhal, David J. Roxby, Devendra K. Hiwase
Publikováno v:
Haematologica, Vol 104, Iss 10 (2019)
Externí odkaz:
https://doaj.org/article/71396d0095bc45f3a16716e563d1776f
Autor:
Deepak Singhal, Monika M. Kutyna, Rakchha Chhetri, Li Yan A. Wee, Sophia Hague, Lakshmi Nath, Shriram V. Nath, Romi Sinha, Nicholas Wickham, Ian D. Lewis, David M. Ross, Peter G. Bardy, Luen Bik To, John Reynolds, Erica M. Wood, David J. Roxby, Devendra K. Hiwase
Publikováno v:
Haematologica, Vol 102, Iss 12 (2017)
Up to 90% of patients with a myelodysplastic syndrome require red blood cell transfusion; nevertheless, comprehensive data on red cell alloimmunization in such patients are limited. This study evaluates the incidence and clinical impact of red cell a
Externí odkaz:
https://doaj.org/article/a2ecb2656a8c4804b08c46a80243be1d
Autor:
Monika M Kutyna, Chung Hoow Kok, Yoon Lim, David Campbell, Sharon Paton, Chloe AL Thompson-Peach, Kelly SY Lim, Timothy Hughes, Sharad Kumar, Daniel Thomas, Stan Gronthos, Devendra Hiwase
Publikováno v:
Blood. 140:9755-9756
Autor:
Mithun V. Shah, Christopher N Hahn, Elizabeth Ngoc Hoa Tran, Kirsty M Sharplin, Rakchha Chhetri, Anmol Baranwal, Monika M Kutyna, Paul Wang, Dariusz Ladon, Aref Al-Kali, Hassan B. Alkhateeb, David M Ross, David T Yeung, Naranie Shanmuganathan, Mark R. Litzow, Abhishek A. Mangaonkar, William J. Hogan, Naseema Gangat, Mrinal M.M. Patnaik, Begna Kebede, Sharad Kumar, Deepak Singhal, Anna L. Brown, Hamish S Scott, Daniel Thomas, Chung Hoow Kok, Ayalew Tefferi, Devendra Hiwase
Publikováno v:
Blood. 140:9798-9799
Autor:
Mithun V. Shah, Christopher N Hahn, Rakchha Chhetri, Elizabeth Ngoc Hoa Tran, Deepak Singhal, William J. Hogan, Monika M Kutyna, Hassan B. Alkhateeb, Aref Al-Kali, Naseema Gangat, Mark R. Litzow, Begna Kebede, Abhishek A. Mangaonkar, Mrinal M. Patnaik, Ayalew Tefferi, Anmol Baranwal, Naranie Shanmuganathan, Sharad Kumar, Daniel Thomas, Chung Hoow Kok, Devendra Hiwase
Background: Therapy-related myeloid neoplasm (t-MN), is a heterogenous entity that includes therapy-related myelodysplastic syndromes (t-MDS), myelodysplastic syndrome/myeloproliferative neoplasms (t-MDS/MPN), and acute myeloid leukemia (t-AML) pheno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28668cfbb4af16d0f0277310a2e1c346
https://hdl.handle.net/11541.2/33154
https://hdl.handle.net/11541.2/33154
Autor:
Monika M. Kutyna, Sophie Loone, Verity A. Saunders, Deborah L. White, Chung H. Kok, Devendra K. Hiwase
Publikováno v:
International Journal of Molecular Sciences
Volume 24
Issue 4
Pages: 3553
Volume 24
Issue 4
Pages: 3553
Azacitidine (AZA) is commonly used hypomethylating agent for higher risk myelodysplastic syndromes and acute myeloid leukemia (AML). Although some patients achieve remission, eventually most patients fail AZA therapy. Comprehensive analysis of intrac
Autor:
Christopher N. Hahn, Sarah Moore, Simone Feurstein, Devendra K Hiwase, Jinghua Feng, Swetansu Pattnaik, Deepak Singhal, Leila Eshraghi, Richard J D'Andrea, Li Yan A Wee, Hamish S. Scott, Monika M Kutyna, Anna L. Brown, Milena Babic, Paul Ps Wang, Andreas W. Schreiber, David Thomas, Wendy T Parker, Luke D Moma, Lucy A. Godley, Song Gao, Rakchha Chhetri, Soma Das, Daniel Thomas, Nicola K. Poplawski
The majority of studies assessing the contribution of pathogenic germline variants (PGVs) to cancer predisposition have focused on patients with single cancers. We analyzed 45 known cancer predisposition genes (CPGs) in germline samples of 202 patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ecc856cdce965fb041a03d4e55c4b18
https://hdl.handle.net/11541.2/147074
https://hdl.handle.net/11541.2/147074
Autor:
Deepak, Singhal, Christopher N, Hahn, Simone, Feurstein, Li Yan A, Wee, Luke, Moma, Monika M, Kutyna, Rakchha, Chhetri, Leila, Eshraghi, Andreas W, Schreiber, Jinghua, Feng, Paul P-S, Wang, Milena, Babic, Wendy T, Parker, Song, Gao, Sarah, Moore, Soma, Das, David, Thomas, Swetansu, Pattnaik, Anna L, Brown, Richard J, D'Andrea, Nicola K, Poplawski, Daniel, Thomas, Hamish S, Scott, Lucy A, Godley, Devendra K, Hiwase
Publikováno v:
Leukemia. 35(11)
The majority of studies assessing the contribution of pathogenic germline variants (PGVs) to cancer predisposition have focused on patients with single cancers. We analyzed 45 known cancer predisposition genes (CPGs) in germline samples of 202 patien